Cel Targeted radionuclide therapy (TRT) has been used as a systemic treatment modality for a range of cancers for 70 years. Its use will increase in Europe as new treatments are introduced into the clinic. However, quantitative analysis of energy deposition ha s seldom been carried out, and treatment strategies vary widely between centres. Internal dosimetry is becoming increasingly necessary to fully assess and compare treatment strategies.This project will develop methodologies to formulate treatment planning for TRT, as is carried out routinely for external beam radiotherapy, and as is required by a recent European directive. Two main aspects will be considered; internal dosimetry and fractionation administration. Techniques for cellular dosimetry will be expl ored and the absorbed doses at this scale will be calculated for radionuclides used for therapy. This information is necessary to help determine the optimal radionuclides to treat patients with metastatic spread and minimal residual disease.At present the number and level of radioactive fractions administered for any given therapy varies widely across Europe. The methodology to quantitatively analyse and compare fractionation options will be developed, and the relevant parameters will be examined in isolati on and in terms of their interactions. An accurate method to compare absorbed doses with successive treatments will be developed to enable treatment to be monitored and modified as it progresses.Results from the internal dosimetry and the fractionation stu dy will be used to form a theoretical and computational model for treatment planning. This model will be applied to clinical data acquired from I-131 mIBG therapy for adult and paediatric neuroendocrine disease and Y-90 monoclonal antibody therapy of lymph oma. This translational research project will provide support for clinical decision making and will provide the evidence base necessary to further optimise treatment on an individual patient basis. Dziedzina nauki medical and health sciencesclinical medicineoncologymedical and health sciencesbasic medicineimmunologyimmunotherapynatural scienceschemical sciencesnuclear chemistryradiation chemistry Słowa kluczowe fractionation internal dosimetry nuclear medicine planning targeted radionuclide therapy therapy treatment planning treatment Program(-y) FP6-MOBILITY - Human resources and Mobility in the specific programme for research, technological development and demonstration "Structuring the European Research Area" under the Sixth Framework Programme 2002-2006 Temat(-y) MOBILITY-2.1 - Marie Curie Intra-European Fellowships (EIF) Zaproszenie do składania wniosków FP6-2002-MOBILITY-5 Zobacz inne projekty w ramach tego zaproszenia System finansowania EIF - Marie Curie actions-Intra-European Fellowships Koordynator INSTITUTE OF CANCER RESEARCH: ROYAL CANCER HOSPITAL Wkład UE Brak danych Adres 123 OLD BROMPTON ROAD LONDON Zjednoczone Królestwo Zobacz na mapie Linki Strona internetowa Opens in new window Koszt całkowity Brak danych